Sequenom, Inc.’s patent infringement suit against Ibis Biosciences, Inc. (IBIS), formerly a subsidiary of Isis Pharmaceuticals, Inc., was dismissed in October 2009.
In October 2008, the Company sued IBIS in the…
A claims construction hearing in Amgen Inc.’s patent infringement lawsuit against Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd. and Barr Laboratories, Inc. is set for Jan. 25 and Jan.…
Genzyme Corporation is pursuing a Hectorol patent infringement action against Roxane Laboratories, Inc., in the U.S. District Court for the District of Delaware.
On July 31, 2009, the company filed a…
Genzyme Corporation’s patent infringement suit against Eagle Pharmaceuticals, Inc., remains pending in the U.S. District Court for the District of Delaware.
In March 2009, the company received notice that Eagle had…
Genzyme Corporation and its wholly owned subsidiary Bone Care International, LLC, pursue a Hectorol patent infringement complaint against Sandoz Inc.
In June 2009, the company received notice that Sandoz had submitted…
DISH Network Corp.’s case declaratory judgment action against Finisar Corp. is stayed until the DirecTV Group Inc. action is resolved.
The Company’s action has been stayed pending the decision of the…
The settlement of the patent infringement suit captioned “Forest Laboratories, Inc. et al. v. Caraco Pharmaceutical Laboratories, Ltd. et al.,” remains subject to review by the U.S. Federal Trade Commission.
In…
Pfizer Inc. pursues a patent infringement action against Matrix Laboratories Limited, Mylan Inc., and another subsidiary of Mylan.
In May 2009, Matrix, a subsidiary of Mylan, notified the Company that it…
Allergan Inc.’s consolidated patent infringement suit against Exela PharmSci Inc. and Apotex Inc. is ongoing in the U.S. District Court for the District of Delaware.
In February 2007, the Company and…
Allergan Inc.’s patent infringement complaint against Barr Laboratories, Inc., is pending in the U.S. District Court for the District of Delaware.
In March 2009, the Company received a paragraph 4 invalidity…